T.Man Pharmaceutical PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	399.31	348.39	348.04	307.17	22.19
Short-Term Investments	352.3	450	-	-	-
Cash & Short-Term Investments	751.62	798.39	348.04	307.17	22.19
Cash Growth	-5.86%	129.40%	13.30%	1284.31%	-66.83%
Accounts Receivable	848.11	596.4	577.79	507.27	256.08
Other Receivables	189.97	20.57	38.75	21.37	23.94
Receivables	1,038	616.97	616.54	528.64	280.02
Inventory	612.66	541.45	481.82	357.96	308.9
Other Current Assets	3.15	3.51	4.99	32.2	4.21
Total Current Assets	2,406	1,960	1,451	1,226	615.32
Property, Plant & Equipment	1,204	1,143	1,048	930.41	742.63
Long-Term Investments	-	200	-	-	-
Other Intangible Assets	45.15	33.84	25.69	12.56	1.23
Long-Term Deferred Tax Assets	45.24	34.25	38.89	40.69	-
Other Long-Term Assets	83.71	84	63.18	68.24	199.02
Total Assets	3,784	3,456	2,627	2,278	1,558
Accounts Payable	507.62	380.62	331.91	333.08	192.3
Short-Term Debt	875	1,080	503.43	535	614.57
Current Portion of Long-Term Debt	-	-	33.08	22	16.01
Current Portion of Leases	5.17	5.66	7.08	4.55	3.01
Current Income Taxes Payable	54.74	27.53	22.63	110.2	11.34
Current Unearned Revenue	100.68	72.01	100.29	73.8	-
Other Current Liabilities	10.09	10.27	23.98	20.46	59.06
Total Current Liabilities	1,553	1,576	1,022	1,099	896.29
Long-Term Debt	-	-	-	33.08	8.33
Long-Term Leases	63.28	64.95	47.89	44.36	28.28
Pension & Post-Retirement Benefits	49.02	44.09	35.18	32.13	28.21
Other Long-Term Liabilities	1.1	0.58	2.39	26.93	25.89
Total Liabilities	1,667	1,686	1,108	1,236	987
Common Stock	300	300	246.43	187.3	187.3
Additional Paid-In Capital	1,394	1,394	305.88	305.88	305.88
Retained Earnings	674.88	327.82	993.46	575.48	103.91
Comprehensive Income & Other	-251.78	-251.78	-26.37	-26.37	-24.95
Total Common Equity	2,117	1,770	1,519	1,042	572.14
Minority Interest	0	-0	0	0	-0.93
Shareholders' Equity	2,117	1,770	1,519	1,042	571.21
Total Liabilities & Equity	3,784	3,456	2,627	2,278	1,558
Total Debt	943.46	1,151	591.48	638.99	670.21
Net Cash (Debt)	-191.84	-352.22	-243.44	-331.82	-648.02
Net Cash Per Share	-0.48	-1.03	-0.88	-1.33	-8.98
Filing Date Shares Outstanding	400	400	328.57	249.73	249.73
Total Common Shares Outstanding	400	400	328.57	249.73	249.73
Working Capital	852.2	384.21	428.98	126.89	-280.97
Book Value Per Share	5.29	4.42	4.62	4.17	2.29
Tangible Book Value	2,072	1,736	1,494	1,030	570.91
Tangible Book Value Per Share	5.18	4.34	4.55	4.12	2.29
Land	124.07	124.07	108.09	94.16	64.95
Buildings	1,166	1,104	1,014	897.56	713.66
Machinery	597.82	610.1	548.56	448.73	415.39
Construction In Progress	84.1	81.02	68.6	93.44	82.16

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.